Alison leads the ABPI Commercial function and is responsible for all the Association’s work on the Value & Access imperatives and all other commercial issues.
Alison Clough, ABPI Executive Director - Commercial UK, responds to NICE Chairman, David Haslam's, interview with Pharmafocus last month.Read more
Medicines play a crucial role in maintaining health, preventing illness, managing chronic conditions and curing disease. However, there is a growing body of evidence that shows us that there is an urgent need to get the fundamentals of medicines use right.Read more
In the second of a series of blogs in the run up to the ABPI annual conference –‘Securing a future for innovative medicines’ – Alison Clough, Commercial Director of the ABPI, looks at how the commercial environment needs to work with the evolving research and development (R&D) ecosystem.Read more
Last week the pharmaceutical industry agreed with the Government a new 5 year deal to help ensure that patients across the UK get the medicines they need, when they need them. Read more
Last week ABPI members heard the latest research into the behaviours of patients in taking their medicines and were presented with opportunities around industry’s role in patient adherence.Read more
The Association of the British Pharmaceutical Industry (ABPI) today/weds announces the appointment of a new medical and innovation director. Read more
The DH and the ABPI wish to clarify that neither party is commenting on any speculation on the content of these negotiations.Read more